Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New NCCN Guidelines for Patients: Pediatric Acute Lymphoblastic Leukemia offers a comprehensive look at the latest expert recommendations.
The trial will test the drug acalabrutinib in those with acute myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndromes.
Here’s a list of approved drugs to treat leukemia including acute lymphocytic or lymphoblastic leukemia (ALL), chronic lymphocytic le...
Tecartus led to durable remission in a majority of participants in a Phase II study.
Hispanic blood cancer patients living at the U.S./Mexico border may have lower overall survival than those who live in other parts of Texas.
Researchers designed a calculator to predict who among those receiving treatment for two forms of acute leukemia are at highest risk.
Investigators wanted to see if blinatumomab could increase survival rates free from leukemia and be less toxic than intensive chemotherapy.
Recent legislation may help narrow the gap between FDA approval of cancer medications for adults and children.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
“I was able to give someone a second chance on life in exchange for being sore for a couple of days. That made it easy for me to say yes,”
“SNL” alum and cancer survivor Vanessa Bayer has written a book with lessons for kids—and adults.
Asparlas approved for children and young adults with acute lymphoblastic leukemia.
Long-term remission seen in children with leukemia and adults with lymphoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.